242 related articles for article (PubMed ID: 2465527)
1. Activation of pp60c-src transforming potential by mutations altering the structure of an amino terminal domain containing residues 90-95.
Potts WM; Reynolds AB; Lansing TJ; Parsons JT
Oncogene Res; 1988; 3(4):343-55. PubMed ID: 2465527
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the cellular src protein tyrosine kinase: interactions of the carboxyl terminal sequences residing between the kinase domain and tyrosine-527.
Cobb BS; Parsons JT
Oncogene; 1993 Nov; 8(11):2897-903. PubMed ID: 7692368
[TBL] [Abstract][Full Text] [Related]
3. The amino-terminal region of pp60c-src has a modulatory role and contains multiple sites of tyrosine phosphorylation.
Espino PC; Harvey R; Schweickhardt RL; White GA; Smith AE; Cheng SH
Oncogene; 1990 Mar; 5(3):283-93. PubMed ID: 1690377
[TBL] [Abstract][Full Text] [Related]
4. Mutational activation of pp60(c-src) leads to a tumorigenic phenotype in a preneoplastic Syrian hamster embryo cell line.
Lansing TJ; Turk BF; Kanner SB; Gilmer TM
Cancer Res; 1997 May; 57(10):1962-9. PubMed ID: 9157992
[TBL] [Abstract][Full Text] [Related]
5. Activation of pp60c-src tyrosine kinase specific activity in tumor-derived Syrian hamster embryo cells.
Kanner SB; Parsons SJ; Parsons JT; Gilmer TM
Oncogene; 1988 Apr; 2(4):327-35. PubMed ID: 2452399
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects of carboxyl terminal truncation and point mutations on pp60c-src activities.
Yaciuk P; Cannella MT; Shalloway D
Oncogene Res; 1988 Sep; 3(2):207-12. PubMed ID: 2465526
[TBL] [Abstract][Full Text] [Related]
7. Purification of bovine thymus cytosolic C-terminal Src kinase (CSK) and demonstration of differential efficiencies of phosphorylation and inactivation of p56lyn and pp60c-src by CSK.
Cheng HC; Bjorge JD; Aebersold R; Fujita DJ; Wang JH
Biochemistry; 1996 Sep; 35(36):11874-87. PubMed ID: 8794770
[TBL] [Abstract][Full Text] [Related]
8. The amino-terminal half of pp59c-fyn contains sequences necessary for formation of a 75 kDa form and also repressive elements absent in pp60c-src.
Espino PC; Chou WY; Smith AE; Cheng SH
Oncogene; 1992 Feb; 7(2):317-22. PubMed ID: 1372400
[TBL] [Abstract][Full Text] [Related]
9. From c-src to v-src, or the case of the missing C terminus.
Sefton BM; Hunter T
Cancer Surv; 1986; 5(2):159-72. PubMed ID: 2430701
[TBL] [Abstract][Full Text] [Related]
10. Cell transformation and activation of pp60c-src by overexpression of a protein tyrosine phosphatase.
Zheng XM; Wang Y; Pallen CJ
Nature; 1992 Sep; 359(6393):336-9. PubMed ID: 1383828
[TBL] [Abstract][Full Text] [Related]
11. Insulin and phorbol ester induce distinct phosphorylations of pp60c-src in the BC3H-1 murine myocyte cell line.
Luttrell LM; Luttrell DK; Parsons SJ; Rogol AD
Oncogene; 1989 Mar; 4(3):317-24. PubMed ID: 2468125
[TBL] [Abstract][Full Text] [Related]
12. Regulation of c-Src tyrosine kinase activity by the Src SH2 domain.
Liu X; Brodeur SR; Gish G; Songyang Z; Cantley LC; Laudano AP; Pawson T
Oncogene; 1993 May; 8(5):1119-26. PubMed ID: 7683128
[TBL] [Abstract][Full Text] [Related]
13. Analysis of mutant forms of the c-src gene product containing a phenylalanine substitution for tyrosine 416.
Ferracini R; Brugge J
Oncogene Res; 1990; 5(3):205-19. PubMed ID: 1690870
[TBL] [Abstract][Full Text] [Related]
14. In vivo phosphorylation states and kinase activities of transforming p60c-src mutants.
Jove R; Hanafusa T; Hamaguchi M; Hanafusa H
Oncogene Res; 1989; 5(1):49-60. PubMed ID: 2476707
[TBL] [Abstract][Full Text] [Related]
15. Myristylation and amino-terminal phosphorylation are required for activation of pp60c-src during mitosis.
Kaech S; Schnierle B; Wyss A; Ballmer-Hofer K
Oncogene; 1993 Mar; 8(3):575-81. PubMed ID: 7679790
[TBL] [Abstract][Full Text] [Related]
16. Tyrosine phosphorylation of a 120,000 dalton membrane-associated protein by the neural form of pp60c-src, pp60c-src+.
Flynn DC; Schaller MD; Parsons JT
Oncogene; 1992 Mar; 7(3):579-83. PubMed ID: 1372401
[TBL] [Abstract][Full Text] [Related]
17. Avian pp60c-src is more active when expressed in yeast than in vertebrate fibroblasts.
Cooper JA; Runge K
Oncogene Res; 1987; 1(4):297-310. PubMed ID: 2453017
[TBL] [Abstract][Full Text] [Related]
18. Single point mutations in the SH2 domain impair the transforming potential of vav and fail to activate proto-vav.
Katzav S
Oncogene; 1993 Jul; 8(7):1757-63. PubMed ID: 8510922
[TBL] [Abstract][Full Text] [Related]
19. Acidic residues at the carboxyl terminus of p60c-src are required for regulation of tyrosine kinase activity and transformation.
MacAuley A; Cooper JA
New Biol; 1990 Sep; 2(9):828-40. PubMed ID: 1703788
[TBL] [Abstract][Full Text] [Related]
20. Modulation of pp60c-src tyrosine kinase activity during secretion in stimulated bovine adrenal chromaffin cells.
Oddie KM; Litz JS; Balserak JC; Payne DM; Creutz CE; Parsons SJ
J Neurosci Res; 1989 Sep; 24(1):38-48. PubMed ID: 2478720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]